Wall Street futures are trading little changed at this hour in the premarket session on Thursday (July 17). Dow Jones futures ...

Abbott Laboratories(NYSE:ABT) reported its second-quarter 2025 results on July 17, 2025, posting 7.5% organic sales growth (excluding COVID testing), 12% medical device growth, and adjusted EPS of $1.

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline innovations.

Abbott, a global healthcare leader, has reported strong results for its second quarter of 2025. According to the company's ...

Elon Musk's dream of having a top-selling electric pickup may be a thing of the past as the Cybertruck continues to see ...

Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories ...

Abbott (NYSE: ABT) shares dipped before hours today on second-quarter results that came in ahead of the consensus forecast.

General Motors' Hummer EV and Ford's F-150 Lightning beat Tesla's Cybertruck in the US electric pick-up market for Q2 2025.

What implications does this carry for Ford and investors? The consequences are serious. Quality issues could damage consumer ...

The inside story of how a CEO and a group of marketers made a last-minute change of plans that now has the Ford brand leading U.S. sales.

Ford is outperforming the S&P 500 with strong Q1 results, solid cash flow, and bullish technicals, despite tariff risks. Find ...